

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 7.99348295 |
| 2 | establishment of skin barrier (GO:0061436) | 7.53034848 |
| 3 | keratinization (GO:0031424) | 7.35733682 |
| 4 | regulation of water loss via skin (GO:0033561) | 7.11002196 |
| 5 | chemical homeostasis within a tissue (GO:0048875) | 6.54278648 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.21089850 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 6.21089850 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.03615676 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 6.03615676 |
| 10 | keratinocyte proliferation (GO:0043616) | 5.82393467 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.65297887 |
| 12 | multicellular organismal water homeostasis (GO:0050891) | 5.62405471 |
| 13 | keratinocyte differentiation (GO:0030216) | 5.45328101 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.36961444 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.25651725 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 5.24783764 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 5.24783764 |
| 18 | tryptophan catabolic process (GO:0006569) | 5.24783764 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.15542400 |
| 20 | urea cycle (GO:0000050) | 5.10635816 |
| 21 | urea metabolic process (GO:0019627) | 5.10635816 |
| 22 | cysteine metabolic process (GO:0006534) | 4.94203904 |
| 23 | bile acid biosynthetic process (GO:0006699) | 4.93785771 |
| 24 | negative regulation of complement activation (GO:0045916) | 4.93129638 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.91674857 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.91247185 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.90755014 |
| 28 | water homeostasis (GO:0030104) | 4.84501973 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.81766772 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 4.74753179 |
| 31 | peptide cross-linking (GO:0018149) | 4.73951183 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.61895654 |
| 33 | negative regulation of protein activation cascade (GO:2000258) | 4.61492715 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.60550522 |
| 35 | protein carboxylation (GO:0018214) | 4.60550522 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.58373974 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.57159076 |
| 38 | gap junction assembly (GO:0016264) | 4.55529993 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.54593394 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.47076773 |
| 41 | glycine metabolic process (GO:0006544) | 4.40549158 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37014591 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.32957615 |
| 44 | complement activation, alternative pathway (GO:0006957) | 4.31387868 |
| 45 | negative regulation of humoral immune response (GO:0002921) | 4.31294393 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.30916003 |
| 47 | bile acid metabolic process (GO:0008206) | 4.30424643 |
| 48 | regulation of complement activation (GO:0030449) | 4.28771899 |
| 49 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.27911781 |
| 50 | hemidesmosome assembly (GO:0031581) | 4.27834098 |
| 51 | phospholipid efflux (GO:0033700) | 4.24875263 |
| 52 | skin morphogenesis (GO:0043589) | 4.19576702 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.17151954 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.17151954 |
| 55 | epidermal cell differentiation (GO:0009913) | 4.16850137 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 4.15167984 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 4.15068503 |
| 58 | cellular glucuronidation (GO:0052695) | 4.10388800 |
| 59 | desmosome organization (GO:0002934) | 4.09712660 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 4.05117650 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.05117650 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.05117650 |
| 63 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.03935605 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 4.03722522 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.02848706 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.02848706 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.00871348 |
| 68 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.00460404 |
| 69 | lysine metabolic process (GO:0006553) | 3.96827708 |
| 70 | lysine catabolic process (GO:0006554) | 3.96827708 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.96708325 |
| 72 | negative regulation of lipase activity (GO:0060192) | 3.96097199 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 3.94957776 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.92863884 |
| 75 | epidermis development (GO:0008544) | 3.92083991 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90582506 |
| 77 | intestinal epithelial cell development (GO:0060576) | 3.89549428 |
| 78 | ethanol oxidation (GO:0006069) | 3.89495487 |
| 79 | fibrinolysis (GO:0042730) | 3.85456117 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.81942415 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.79471332 |
| 82 | tyrosine metabolic process (GO:0006570) | 3.78921665 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77994096 |
| 84 | hair cycle (GO:0042633) | 3.73339879 |
| 85 | molting cycle (GO:0042303) | 3.73339879 |
| 86 | establishment of tissue polarity (GO:0007164) | 3.71047830 |
| 87 | establishment of planar polarity (GO:0001736) | 3.71047830 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.68108748 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.65835246 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.64612431 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 3.64551784 |
| 92 | amine catabolic process (GO:0009310) | 3.64551784 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.63974825 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.63974825 |
| 95 | Golgi transport vesicle coating (GO:0048200) | 3.62687107 |
| 96 | COPI coating of Golgi vesicle (GO:0048205) | 3.62687107 |
| 97 | drug catabolic process (GO:0042737) | 3.59904397 |
| 98 | primary alcohol catabolic process (GO:0034310) | 3.59592342 |
| 99 | protein localization to endosome (GO:0036010) | 3.56429025 |
| 100 | carnitine metabolic process (GO:0009437) | 3.54710294 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 3.54524809 |
| 102 | hypotonic response (GO:0006971) | 3.53694394 |
| 103 | response to nitrosative stress (GO:0051409) | 3.51786056 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.51708524 |
| 105 | cholesterol efflux (GO:0033344) | 3.50624101 |
| 106 | cell-substrate junction assembly (GO:0007044) | 3.50400995 |
| 107 | ethanol metabolic process (GO:0006067) | 3.50200318 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.50016216 |
| 109 | xenobiotic catabolic process (GO:0042178) | 3.48308710 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.47806146 |
| 111 | sterol homeostasis (GO:0055092) | 3.45148086 |
| 112 | iron ion import (GO:0097286) | 3.44907967 |
| 113 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.43216652 |
| 114 | glutamate metabolic process (GO:0006536) | 3.41402583 |
| 115 | keratinocyte development (GO:0003334) | 3.38043173 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.37803953 |
| 117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36543473 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36543473 |
| 119 | arginine metabolic process (GO:0006525) | 3.35864437 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 3.35290395 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 3.34441662 |
| 122 | regulation of keratinocyte proliferation (GO:0010837) | 3.30246131 |
| 123 | diterpenoid biosynthetic process (GO:0016102) | 3.28653569 |
| 124 | intestinal cholesterol absorption (GO:0030299) | 3.28413260 |
| 125 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25116129 |
| 126 | lipoprotein metabolic process (GO:0042157) | 3.24323154 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 3.23727276 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 3.23105793 |
| 129 | organic acid catabolic process (GO:0016054) | 3.23105793 |
| 130 | positive regulation of lipid catabolic process (GO:0050996) | 3.22919080 |
| 131 | regulation of keratinocyte differentiation (GO:0045616) | 3.21227823 |
| 132 | aldehyde catabolic process (GO:0046185) | 3.19588435 |
| 133 | coenzyme catabolic process (GO:0009109) | 3.14270450 |
| 134 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.12930287 |
| 135 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.12587731 |
| 136 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.10871609 |
| 137 | drug metabolic process (GO:0017144) | 3.10719263 |
| 138 | interferon-gamma secretion (GO:0072643) | 3.10310719 |
| 139 | membrane raft organization (GO:0031579) | 3.07366273 |
| 140 | intermediate filament organization (GO:0045109) | 3.04979230 |
| 141 | cellular response to vitamin D (GO:0071305) | 3.04622890 |
| 142 | regulation of transforming growth factor beta production (GO:0071634) | 2.94004860 |
| 143 | complement activation, classical pathway (GO:0006958) | 2.90955159 |
| 144 | endothelial cell chemotaxis (GO:0035767) | 2.73769292 |
| 145 | ectoderm development (GO:0007398) | 2.73562145 |
| 146 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.72399408 |
| 147 | membrane budding (GO:0006900) | 2.72372478 |
| 148 | retinal metabolic process (GO:0042574) | 2.71129176 |
| 149 | complement activation (GO:0006956) | 2.70151002 |
| 150 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.69439796 |
| 151 | regulation of metalloenzyme activity (GO:0048552) | 2.67737736 |
| 152 | protein autoprocessing (GO:0016540) | 2.67374502 |
| 153 | positive regulation of epidermis development (GO:0045684) | 2.65908316 |
| 154 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.65361140 |
| 155 | renal filtration (GO:0097205) | 2.64729742 |
| 156 | epithelial cell-cell adhesion (GO:0090136) | 2.64023577 |
| 157 | sphingomyelin metabolic process (GO:0006684) | 2.62826156 |
| 158 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.58682309 |
| 159 | one-carbon compound transport (GO:0019755) | 2.56965984 |
| 160 | O-glycan processing (GO:0016266) | 2.56653480 |
| 161 | sphingoid metabolic process (GO:0046519) | 2.56228491 |
| 162 | lung lobe morphogenesis (GO:0060463) | 2.54396920 |
| 163 | sphingosine metabolic process (GO:0006670) | 2.50990351 |
| 164 | protein activation cascade (GO:0072376) | 2.50920536 |
| 165 | lipoxygenase pathway (GO:0019372) | 2.50864300 |
| 166 | substrate-dependent cell migration (GO:0006929) | 2.48036972 |
| 167 | response to vitamin D (GO:0033280) | 2.46682818 |
| 168 | detection of bacterium (GO:0016045) | 2.46593934 |
| 169 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.45815967 |
| 170 | wound healing (GO:0042060) | 2.45739818 |
| 171 | phosphate ion transmembrane transport (GO:0035435) | 2.42084605 |
| 172 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.42022833 |
| 173 | diol metabolic process (GO:0034311) | 2.40936443 |
| 174 | polarized epithelial cell differentiation (GO:0030859) | 2.37655071 |
| 175 | COPII vesicle coating (GO:0048208) | 2.37467436 |
| 176 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.36463585 |
| 177 | detection of other organism (GO:0098543) | 2.36275622 |
| 178 | regulation of humoral immune response (GO:0002920) | 2.29596538 |
| 179 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.29512660 |
| 180 | regulation of epidermis development (GO:0045682) | 2.26501709 |
| 181 | cell-cell junction assembly (GO:0007043) | 2.26251786 |
| 182 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.25069882 |
| 183 | renal absorption (GO:0070293) | 2.24042688 |
| 184 | regulation of chemokine secretion (GO:0090196) | 2.23274687 |
| 185 | hepatocyte differentiation (GO:0070365) | 2.22647696 |
| 186 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.22478965 |
| 187 | terpenoid biosynthetic process (GO:0016114) | 2.21236869 |
| 188 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.18688593 |
| 189 | ganglion development (GO:0061548) | 2.18598631 |
| 190 | glomerular filtration (GO:0003094) | 2.18203340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.68299994 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.46569197 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16922462 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.60752057 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.02163714 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.75778419 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.25708105 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11495950 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.78939150 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.78385940 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.05917668 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73104573 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12766406 |
| 14 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.12730266 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09849857 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01448126 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87090696 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84534279 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84374193 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.83854975 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81387433 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80787842 |
| 23 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.79406976 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.77852705 |
| 25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.77676295 |
| 26 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.77534043 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77165328 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75077692 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72140026 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66488987 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64952343 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64276153 |
| 33 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.58858547 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55551009 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53528964 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.49076656 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46256474 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44093010 |
| 39 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.43532838 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.37883990 |
| 41 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.37486181 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36971386 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35099152 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33303858 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32315514 |
| 46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.31588191 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31290040 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30839239 |
| 49 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29551239 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28597486 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27279880 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20078949 |
| 53 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18240563 |
| 54 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18240563 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16288890 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16208950 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15791648 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15273676 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14919083 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14257681 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14068529 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13485979 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12278227 |
| 64 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11823092 |
| 65 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11808816 |
| 66 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10755740 |
| 67 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10696580 |
| 68 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09240372 |
| 69 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09240372 |
| 70 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09240372 |
| 71 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07383597 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06151302 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06001320 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05294437 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04147138 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03842241 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03577464 |
| 78 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03452315 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03348631 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03348631 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02295121 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02243903 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01847765 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01847765 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01759027 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01573546 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01326220 |
| 88 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98783535 |
| 89 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95486967 |
| 90 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95335620 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94657045 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94611666 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94373959 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93829174 |
| 95 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.92272871 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91968079 |
| 97 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91184959 |
| 98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90343952 |
| 99 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88633424 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86482079 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85788920 |
| 102 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85677779 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85507582 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85007399 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84449686 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83092502 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81996834 |
| 108 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.81640236 |
| 109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79785027 |
| 110 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.79770894 |
| 111 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78733408 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78378527 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77474396 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77209068 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76877868 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76664594 |
| 117 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.76130687 |
| 118 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.75764295 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73853795 |
| 120 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73517448 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72467719 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71585114 |
| 123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.71441260 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.71268083 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70872206 |
| 126 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.70836665 |
| 127 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.70150938 |
| 128 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70035703 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66887085 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66160189 |
| 131 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.65662732 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65374967 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.64654972 |
| 134 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.63006271 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59509885 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.58276886 |
| 137 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.57482127 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55634257 |
| 139 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.55118602 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54997213 |
| 141 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.54482224 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53575950 |
| 143 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.53415627 |
| 144 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.53167632 |
| 145 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.52835361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.12393798 |
| 2 | MP0005360_urolithiasis | 5.66815545 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18381762 |
| 4 | MP0005365_abnormal_bile_salt | 4.66658122 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.16780385 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.66256556 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.34601312 |
| 8 | MP0002254_reproductive_system_inflammat | 2.92774338 |
| 9 | MP0002796_impaired_skin_barrier | 2.92463232 |
| 10 | MP0003252_abnormal_bile_duct | 2.90520778 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.70637801 |
| 12 | MP0009840_abnormal_foam_cell | 2.63470103 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.38438839 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.33537199 |
| 15 | MP0005083_abnormal_biliary_tract | 2.20166115 |
| 16 | MP0003195_calcinosis | 2.13875118 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.06790886 |
| 18 | MP0005332_abnormal_amino_acid | 1.98122763 |
| 19 | MP0000579_abnormal_nail_morphology | 1.85380725 |
| 20 | MP0005409_darkened_coat_color | 1.81671708 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.81613495 |
| 22 | MP0005501_abnormal_skin_physiology | 1.78442762 |
| 23 | MP0010678_abnormal_skin_adnexa | 1.77090245 |
| 24 | MP0003941_abnormal_skin_development | 1.74349129 |
| 25 | MP0002098_abnormal_vibrissa_morphology | 1.74247186 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.74183495 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.73730655 |
| 28 | MP0000609_abnormal_liver_physiology | 1.67496904 |
| 29 | MP0002060_abnormal_skin_morphology | 1.66036095 |
| 30 | MP0009053_abnormal_anal_canal | 1.58848955 |
| 31 | MP0000383_abnormal_hair_follicle | 1.55853667 |
| 32 | MP0004381_abnormal_hair_follicle | 1.54954331 |
| 33 | MP0001216_abnormal_epidermal_layer | 1.54829199 |
| 34 | MP0005275_abnormal_skin_tensile | 1.48751398 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.46403657 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.44495035 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.43949436 |
| 38 | MP0001851_eye_inflammation | 1.39556149 |
| 39 | MP0005451_abnormal_body_composition | 1.39265627 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.37544119 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.36937354 |
| 42 | MP0003724_increased_susceptibility_to | 1.35179319 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.34938753 |
| 44 | MP0000467_abnormal_esophagus_morphology | 1.33527294 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.33079187 |
| 46 | MP0003186_abnormal_redox_activity | 1.32735581 |
| 47 | MP0005164_abnormal_response_to | 1.31810422 |
| 48 | MP0006054_spinal_hemorrhage | 1.27631045 |
| 49 | MP0000377_abnormal_hair_follicle | 1.25324488 |
| 50 | MP0000566_synostosis | 1.25273658 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.22094441 |
| 52 | MP0003011_delayed_dark_adaptation | 1.19824737 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.18955581 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.17199962 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.16698680 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.12569952 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.11313224 |
| 58 | MP0003868_abnormal_feces_composition | 1.10090601 |
| 59 | MP0000647_abnormal_sebaceous_gland | 1.09719796 |
| 60 | MP0001958_emphysema | 1.08597293 |
| 61 | MP0005165_increased_susceptibility_to | 1.07602316 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.07132927 |
| 63 | MP0008004_abnormal_stomach_pH | 1.06891565 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.05557887 |
| 65 | MP0001849_ear_inflammation | 1.04367989 |
| 66 | MP0005023_abnormal_wound_healing | 1.04251757 |
| 67 | MP0001764_abnormal_homeostasis | 1.04031710 |
| 68 | MP0000762_abnormal_tongue_morphology | 1.03941904 |
| 69 | MP0010771_integument_phenotype | 1.03836893 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.03675097 |
| 71 | MP0005248_abnormal_Harderian_gland | 1.03555574 |
| 72 | MP0000427_abnormal_hair_cycle | 1.02467734 |
| 73 | MP0001346_abnormal_lacrimal_gland | 1.01091323 |
| 74 | MP0000858_altered_metastatic_potential | 0.93758409 |
| 75 | MP0003828_pulmonary_edema | 0.92678925 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 0.91432630 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88693582 |
| 78 | MP0005647_abnormal_sex_gland | 0.87255903 |
| 79 | MP0008260_abnormal_autophagy | 0.87225401 |
| 80 | MP0003091_abnormal_cell_migration | 0.85274208 |
| 81 | MP0004883_abnormal_blood_vessel | 0.83566668 |
| 82 | MP0004947_skin_inflammation | 0.83270999 |
| 83 | MP0000598_abnormal_liver_morphology | 0.82637875 |
| 84 | MP0003718_maternal_effect | 0.81583713 |
| 85 | MP0002006_tumorigenesis | 0.81413080 |
| 86 | MP0005388_respiratory_system_phenotype | 0.79820426 |
| 87 | MP0002133_abnormal_respiratory_system | 0.79820426 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.79769253 |
| 89 | MP0004272_abnormal_basement_membrane | 0.79730454 |
| 90 | MP0009931_abnormal_skin_appearance | 0.78714611 |
| 91 | MP0003436_decreased_susceptibility_to | 0.77828587 |
| 92 | MP0009697_abnormal_copulation | 0.77381337 |
| 93 | MP0003045_fibrosis | 0.76958301 |
| 94 | MP0005408_hypopigmentation | 0.76863805 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.76524822 |
| 96 | MP0005166_decreased_susceptibility_to | 0.73424405 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.73385466 |
| 98 | MP0002168_other_aberrant_phenotype | 0.73169236 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.72678086 |
| 100 | MP0009764_decreased_sensitivity_to | 0.72309066 |
| 101 | MP0000627_abnormal_mammary_gland | 0.72179440 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.68801250 |
| 103 | MP0009763_increased_sensitivity_to | 0.68300656 |
| 104 | MP0001243_abnormal_dermal_layer | 0.67666411 |
| 105 | MP0003075_altered_response_to | 0.67514595 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.67455478 |
| 107 | MP0002282_abnormal_trachea_morphology | 0.65849084 |
| 108 | MP0003315_abnormal_perineum_morphology | 0.64257879 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.62846713 |
| 110 | MP0009379_abnormal_foot_pigmentation | 0.62444744 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.62394743 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.62245178 |
| 113 | MP0001191_abnormal_skin_condition | 0.62174709 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.60753417 |
| 115 | MP0000249_abnormal_blood_vessel | 0.60662036 |
| 116 | MP0000367_abnormal_coat/_hair | 0.59381459 |
| 117 | MP0009785_altered_susceptibility_to | 0.58443823 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.58208645 |
| 119 | MP0001881_abnormal_mammary_gland | 0.57932245 |
| 120 | MP0004043_abnormal_pH_regulation | 0.57558399 |
| 121 | MP0004885_abnormal_endolymph | 0.57278312 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.57267264 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.56782150 |
| 124 | MP0001756_abnormal_urination | 0.56153054 |
| 125 | MP0005377_hearing/vestibular/ear_phenot | 0.55253463 |
| 126 | MP0003878_abnormal_ear_physiology | 0.55253463 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.54866167 |
| 128 | MP0003448_altered_tumor_morphology | 0.53006297 |
| 129 | MP0005395_other_phenotype | 0.52375167 |
| 130 | MP0004484_altered_response_of | 0.51667149 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.51371214 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.50251148 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.49780335 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.49521819 |
| 135 | MP0000613_abnormal_salivary_gland | 0.49213415 |
| 136 | MP0005670_abnormal_white_adipose | 0.49134696 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.48651385 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.47954112 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.47636833 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.47067730 |
| 141 | MP0002249_abnormal_larynx_morphology | 0.46984453 |
| 142 | MP0000604_amyloidosis | 0.46037758 |
| 143 | MP0008469_abnormal_protein_level | 0.44312143 |
| 144 | MP0005266_abnormal_metabolism | 0.43879436 |
| 145 | MP0000477_abnormal_intestine_morphology | 0.42339293 |
| 146 | MP0003936_abnormal_reproductive_system | 0.41553685 |
| 147 | MP0000462_abnormal_digestive_system | 0.41219864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.59065892 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.25537435 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.93653171 |
| 4 | Thick nail (HP:0001805) | 5.78810016 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.61364623 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.54897704 |
| 7 | Xanthomatosis (HP:0000991) | 5.30969884 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.92187965 |
| 9 | Onycholysis (HP:0001806) | 4.44548472 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 4.31590206 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.29278603 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.26157050 |
| 13 | Epidermoid cyst (HP:0200040) | 4.13378037 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12487339 |
| 15 | Oral leukoplakia (HP:0002745) | 4.06676865 |
| 16 | Hyperammonemia (HP:0001987) | 3.97574190 |
| 17 | Complement deficiency (HP:0004431) | 3.94311716 |
| 18 | Hyperglycinemia (HP:0002154) | 3.88299682 |
| 19 | Hyperglycinuria (HP:0003108) | 3.85668871 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.77812178 |
| 21 | Abnormality of the axillary hair (HP:0100134) | 3.74062177 |
| 22 | Abnormality of secondary sexual hair (HP:0009888) | 3.74062177 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.73637657 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 3.73125025 |
| 25 | Fat malabsorption (HP:0002630) | 3.65158769 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.62735907 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.59929934 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59929934 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.53081222 |
| 30 | Erythema (HP:0010783) | 3.48694757 |
| 31 | Plantar hyperkeratosis (HP:0007556) | 3.46340377 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.42745828 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.42022058 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.38645016 |
| 35 | Corneal erosion (HP:0200020) | 3.34999629 |
| 36 | Joint hemorrhage (HP:0005261) | 3.26750579 |
| 37 | Fragile nails (HP:0001808) | 3.25103458 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.24753423 |
| 39 | Milia (HP:0001056) | 3.21427212 |
| 40 | Ridged nail (HP:0001807) | 3.17005409 |
| 41 | Abnormality of complement system (HP:0005339) | 3.07575107 |
| 42 | Increased IgE level (HP:0003212) | 3.02431031 |
| 43 | Ketosis (HP:0001946) | 3.01146799 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95728044 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.94764658 |
| 46 | Hyperactive renin-angiotensin system (HP:0000841) | 2.87178642 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.83479064 |
| 48 | Vascular calcification (HP:0004934) | 2.82547082 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78530207 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.76185214 |
| 51 | Steatorrhea (HP:0002570) | 2.75891586 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75326459 |
| 53 | Amelogenesis imperfecta (HP:0000705) | 2.70129954 |
| 54 | Hypoplasia of dental enamel (HP:0006297) | 2.70058608 |
| 55 | Absent eyelashes (HP:0000561) | 2.69244543 |
| 56 | Abnormality of the salivary glands (HP:0010286) | 2.67450691 |
| 57 | Alopecia of scalp (HP:0002293) | 2.66193881 |
| 58 | Malnutrition (HP:0004395) | 2.64304751 |
| 59 | Ectropion (HP:0000656) | 2.64076262 |
| 60 | Spastic diplegia (HP:0001264) | 2.59322576 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.59245706 |
| 62 | Flat acetabular roof (HP:0003180) | 2.58687718 |
| 63 | Chronic bronchitis (HP:0004469) | 2.57951413 |
| 64 | Woolly hair (HP:0002224) | 2.56041299 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.55527202 |
| 66 | Palmoplantar hyperkeratosis (HP:0000972) | 2.54804808 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.52070904 |
| 68 | Abnormal hemoglobin (HP:0011902) | 2.49449144 |
| 69 | Myocardial infarction (HP:0001658) | 2.48205557 |
| 70 | Esophageal varix (HP:0002040) | 2.47671484 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.46111478 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.46111478 |
| 73 | Nail dystrophy (HP:0008404) | 2.45396435 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.44770891 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.43379096 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.42352362 |
| 77 | Abnormality of nail color (HP:0100643) | 2.41982395 |
| 78 | Palmar hyperkeratosis (HP:0010765) | 2.41603594 |
| 79 | Popliteal pterygium (HP:0009756) | 2.40860751 |
| 80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38370500 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.38370500 |
| 82 | Gout (HP:0001997) | 2.37296793 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36609851 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.36449078 |
| 85 | Blepharitis (HP:0000498) | 2.35409804 |
| 86 | Pili torti (HP:0003777) | 2.34652748 |
| 87 | Pustule (HP:0200039) | 2.34375953 |
| 88 | Hypoplastic labia majora (HP:0000059) | 2.31602124 |
| 89 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30789824 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28642727 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.28642727 |
| 92 | Sparse scalp hair (HP:0002209) | 2.28600925 |
| 93 | Lethargy (HP:0001254) | 2.23552528 |
| 94 | Natal tooth (HP:0000695) | 2.23168144 |
| 95 | Xerostomia (HP:0000217) | 2.22733376 |
| 96 | Lip pit (HP:0100267) | 2.22622545 |
| 97 | Dry hair (HP:0011359) | 2.20676554 |
| 98 | Atrophic scars (HP:0001075) | 2.19258298 |
| 99 | Parakeratosis (HP:0001036) | 2.17282635 |
| 100 | Abnormality of permanent molar morphology (HP:0011071) | 2.16946572 |
| 101 | Abnormality of the dental root (HP:0006486) | 2.16946572 |
| 102 | Taurodontia (HP:0000679) | 2.16946572 |
| 103 | Metabolic acidosis (HP:0001942) | 2.15336232 |
| 104 | Hypotrichosis (HP:0001006) | 2.14978253 |
| 105 | Hemorrhage of the eye (HP:0011885) | 2.14757476 |
| 106 | Advanced eruption of teeth (HP:0006288) | 2.14467292 |
| 107 | Spontaneous abortion (HP:0005268) | 2.13925646 |
| 108 | Abnormal hair laboratory examination (HP:0003328) | 2.13789289 |
| 109 | Oligodontia (HP:0000677) | 2.13539782 |
| 110 | Abnormal cartilage morphology (HP:0002763) | 2.11823201 |
| 111 | Rickets (HP:0002748) | 2.10536893 |
| 112 | Pterygium (HP:0001059) | 2.09967689 |
| 113 | Abnormal blistering of the skin (HP:0008066) | 2.09090475 |
| 114 | Selective tooth agenesis (HP:0001592) | 2.08308340 |
| 115 | Arterial tortuosity (HP:0005116) | 2.08228954 |
| 116 | Ventricular tachycardia (HP:0004756) | 2.08186694 |
| 117 | Dehydration (HP:0001944) | 2.06735380 |
| 118 | Autoamputation (HP:0001218) | 2.06239760 |
| 119 | Hypohidrosis (HP:0000966) | 2.05444957 |
| 120 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.05201744 |
| 121 | Abnormality of the dental pulp (HP:0006479) | 2.04393264 |
| 122 | Abnormality of the labia majora (HP:0012881) | 2.03352443 |
| 123 | Abnormality of molar (HP:0011077) | 1.99837768 |
| 124 | Abnormality of molar morphology (HP:0011070) | 1.99837768 |
| 125 | Neonatal onset (HP:0003623) | 1.98865805 |
| 126 | Ketoacidosis (HP:0001993) | 1.98796277 |
| 127 | Gangrene (HP:0100758) | 1.98321190 |
| 128 | Fragile skin (HP:0001030) | 1.95937440 |
| 129 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.95674405 |
| 130 | Abnormality of placental membranes (HP:0011409) | 1.93008942 |
| 131 | Amniotic constriction ring (HP:0009775) | 1.93008942 |
| 132 | Erythroderma (HP:0001019) | 1.92359534 |
| 133 | Ankyloglossia (HP:0010296) | 1.90886425 |
| 134 | Absent hair (HP:0002298) | 1.90125267 |
| 135 | Irritability (HP:0000737) | 1.86285706 |
| 136 | Systemic lupus erythematosus (HP:0002725) | 1.81857123 |
| 137 | Anonychia (HP:0001798) | 1.81728044 |
| 138 | Palpitations (HP:0001962) | 1.81197729 |
| 139 | Pruritus (HP:0000989) | 1.81136358 |
| 140 | Hyperkalemia (HP:0002153) | 1.81048573 |
| 141 | Short nail (HP:0001799) | 1.80006167 |
| 142 | Sparse eyelashes (HP:0000653) | 1.78484276 |
| 143 | Follicular hyperkeratosis (HP:0007502) | 1.78061035 |
| 144 | Abnormality of the gastric mucosa (HP:0004295) | 1.77828936 |
| 145 | Hypodontia (HP:0000668) | 1.77430263 |
| 146 | Skin nodule (HP:0200036) | 1.77275529 |
| 147 | Hoarse voice (HP:0001609) | 1.77258866 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76922355 |
| 149 | Generalized aminoaciduria (HP:0002909) | 1.75780149 |
| 150 | Pancreatitis (HP:0001733) | 1.75692224 |
| 151 | Carious teeth (HP:0000670) | 1.75344591 |
| 152 | Acanthocytosis (HP:0001927) | 1.74573564 |
| 153 | Hyperhidrosis (HP:0000975) | 1.73740978 |
| 154 | Vascular tortuosity (HP:0004948) | 1.72651498 |
| 155 | Multifactorial inheritance (HP:0001426) | 1.72084317 |
| 156 | Curly hair (HP:0002212) | 1.70465583 |
| 157 | Hyperglycemia (HP:0003074) | 1.70116498 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69587545 |
| 159 | Renal cortical cysts (HP:0000803) | 1.66832775 |
| 160 | Abnormality of vitamin metabolism (HP:0100508) | 1.66661711 |
| 161 | Ileus (HP:0002595) | 1.66287188 |
| 162 | Glomerulosclerosis (HP:0000096) | 1.66080406 |
| 163 | Hypoglycemic seizures (HP:0002173) | 1.64479333 |
| 164 | Skin ulcer (HP:0200042) | 1.64155506 |
| 165 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63381488 |
| 166 | Hyperuricemia (HP:0002149) | 1.62808799 |
| 167 | Increased purine levels (HP:0004368) | 1.62808799 |
| 168 | Glomerulonephritis (HP:0000099) | 1.61899369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.92610527 |
| 2 | BCKDK | 3.65955637 |
| 3 | LATS1 | 3.11870249 |
| 4 | FGFR4 | 3.08325262 |
| 5 | MST1R | 2.99041350 |
| 6 | MAP3K3 | 2.90547771 |
| 7 | ERN1 | 2.74350789 |
| 8 | MST4 | 2.52151499 |
| 9 | SIK1 | 2.51573774 |
| 10 | FRK | 2.44115713 |
| 11 | RPS6KB2 | 2.40252755 |
| 12 | STK24 | 2.16583338 |
| 13 | MAPKAPK3 | 2.07789213 |
| 14 | STK38L | 2.03217122 |
| 15 | PKN2 | 1.93447583 |
| 16 | MAP3K12 | 1.89120064 |
| 17 | FER | 1.85377067 |
| 18 | ERBB4 | 1.84245146 |
| 19 | PTK6 | 1.77347451 |
| 20 | MET | 1.55612404 |
| 21 | TRIB3 | 1.51844987 |
| 22 | PIK3CA | 1.51044454 |
| 23 | MAP3K2 | 1.46216781 |
| 24 | CDK6 | 1.45310514 |
| 25 | EIF2AK3 | 1.32289497 |
| 26 | DDR2 | 1.27011573 |
| 27 | EPHB2 | 1.25570405 |
| 28 | PTK2 | 1.23367084 |
| 29 | JAK1 | 1.19557812 |
| 30 | MAP3K9 | 1.18268020 |
| 31 | STK3 | 1.15994398 |
| 32 | MAP3K6 | 1.14905317 |
| 33 | TTK | 1.11478886 |
| 34 | PBK | 1.08725272 |
| 35 | FLT3 | 1.07923286 |
| 36 | PDGFRA | 1.07486694 |
| 37 | ERBB2 | 1.06061120 |
| 38 | NEK6 | 1.04611238 |
| 39 | TYK2 | 1.04030148 |
| 40 | NTRK1 | 1.03863317 |
| 41 | MAP2K2 | 1.03054285 |
| 42 | DYRK1B | 1.00033986 |
| 43 | MAP2K6 | 0.99451533 |
| 44 | MYLK | 0.99182554 |
| 45 | MAPK11 | 0.98635498 |
| 46 | TRPM7 | 0.97542074 |
| 47 | LRRK2 | 0.96329948 |
| 48 | TIE1 | 0.93881581 |
| 49 | STK10 | 0.93655169 |
| 50 | EPHB1 | 0.93450741 |
| 51 | PDGFRB | 0.90218273 |
| 52 | CDK12 | 0.88527913 |
| 53 | EPHA3 | 0.87655046 |
| 54 | FGFR2 | 0.86774338 |
| 55 | NEK9 | 0.86027148 |
| 56 | STK38 | 0.85067683 |
| 57 | PDK2 | 0.84331737 |
| 58 | MAP3K11 | 0.82040500 |
| 59 | BRSK2 | 0.81890855 |
| 60 | LATS2 | 0.81244375 |
| 61 | PIK3CG | 0.80182664 |
| 62 | MAP3K10 | 0.78358308 |
| 63 | AKT3 | 0.78011853 |
| 64 | PDK4 | 0.76839625 |
| 65 | PDK3 | 0.76839625 |
| 66 | EEF2K | 0.76150882 |
| 67 | PAK4 | 0.74287126 |
| 68 | TESK1 | 0.74140390 |
| 69 | ZAP70 | 0.74049723 |
| 70 | PRKCI | 0.74037236 |
| 71 | RIPK1 | 0.72641936 |
| 72 | NEK1 | 0.71804215 |
| 73 | RET | 0.71581498 |
| 74 | MAP3K14 | 0.70813029 |
| 75 | TAOK2 | 0.64282407 |
| 76 | YES1 | 0.63987927 |
| 77 | MAP3K13 | 0.63885146 |
| 78 | MAPK15 | 0.63335465 |
| 79 | CDK4 | 0.62290989 |
| 80 | BMX | 0.61985762 |
| 81 | GRK1 | 0.61206502 |
| 82 | MAP3K8 | 0.61194583 |
| 83 | FGFR1 | 0.60907844 |
| 84 | SCYL2 | 0.60881442 |
| 85 | ARAF | 0.60661927 |
| 86 | MAP2K1 | 0.59698589 |
| 87 | GRK6 | 0.59055004 |
| 88 | WEE1 | 0.59022982 |
| 89 | MAP3K7 | 0.58918367 |
| 90 | IGF1R | 0.58334343 |
| 91 | STK39 | 0.57734784 |
| 92 | PIM2 | 0.56646847 |
| 93 | MAP3K1 | 0.56162781 |
| 94 | ABL2 | 0.54796695 |
| 95 | GSK3A | 0.54006965 |
| 96 | TAOK3 | 0.52330446 |
| 97 | MAPKAPK2 | 0.52161325 |
| 98 | INSRR | 0.51560729 |
| 99 | BMPR2 | 0.50420823 |
| 100 | IRAK3 | 0.49715182 |
| 101 | MAP2K3 | 0.49134242 |
| 102 | MTOR | 0.48001775 |
| 103 | TGFBR1 | 0.46529655 |
| 104 | NUAK1 | 0.46023578 |
| 105 | FGFR3 | 0.45591101 |
| 106 | TBK1 | 0.44501960 |
| 107 | RPS6KA4 | 0.44063361 |
| 108 | SIK3 | 0.43017348 |
| 109 | JAK2 | 0.42051748 |
| 110 | CHUK | 0.41818037 |
| 111 | AURKB | 0.41717864 |
| 112 | BCR | 0.41641946 |
| 113 | MATK | 0.41614285 |
| 114 | CDK7 | 0.40919966 |
| 115 | TGFBR2 | 0.40694531 |
| 116 | IRAK1 | 0.40548423 |
| 117 | CDC42BPA | 0.40225958 |
| 118 | EIF2AK1 | 0.39936764 |
| 119 | LMTK2 | 0.38466532 |
| 120 | CSF1R | 0.37315328 |
| 121 | ABL1 | 0.36442577 |
| 122 | CSNK1E | 0.36381448 |
| 123 | PRKCE | 0.36220444 |
| 124 | TSSK6 | 0.36134591 |
| 125 | NME2 | 0.35070967 |
| 126 | ZAK | 0.33825214 |
| 127 | PDPK1 | 0.33606104 |
| 128 | RPS6KB1 | 0.33357098 |
| 129 | PRKAA2 | 0.32786344 |
| 130 | RPS6KA1 | 0.31769058 |
| 131 | DMPK | 0.30653722 |
| 132 | CSK | 0.29874518 |
| 133 | CDK8 | 0.28907371 |
| 134 | IKBKB | 0.28857280 |
| 135 | SGK3 | 0.28284992 |
| 136 | SRC | 0.28142415 |
| 137 | NME1 | 0.27816070 |
| 138 | EGFR | 0.27788217 |
| 139 | PRKCD | 0.27074526 |
| 140 | MAP3K5 | 0.24995287 |
| 141 | MAPK4 | 0.24943092 |
| 142 | NLK | 0.24100122 |
| 143 | ERBB3 | 0.23926658 |
| 144 | MELK | 0.22628694 |
| 145 | CSNK1D | 0.22550992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91709691 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44541318 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97649946 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95437369 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73884687 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.54054998 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48437689 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.47782257 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.45410063 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.44167901 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42702778 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36847713 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34452062 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.34087122 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18130516 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.17237486 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14821507 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.08559242 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.04401314 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.02331704 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.97989595 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95649588 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.85766064 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84757801 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.83006357 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82244101 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80542239 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.80452049 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70305414 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70293857 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69662961 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62949379 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62647966 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59786994 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52282601 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.51559054 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49837291 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48508438 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45418484 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41224434 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39357572 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38656348 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36330357 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31833128 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.26766223 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25570259 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24755208 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24532820 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 1.23145464 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20872943 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20598018 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19967609 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19263517 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18312154 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17599150 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15373571 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14885655 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14424096 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14409249 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12787704 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12387973 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12200362 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08574832 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08038996 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06188106 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 1.03914823 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02098434 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01603007 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 1.00374814 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.98042522 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.97362625 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93695059 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.92969001 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91895028 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90589175 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88499108 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87378502 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85881053 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84268401 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84113339 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.83319954 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83277395 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.80328647 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80313138 |
| 85 | Malaria_Homo sapiens_hsa05144 | 0.78993936 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77686825 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76554682 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72704057 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70572249 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67779094 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66667224 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66024430 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65004233 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62988470 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62982537 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62781990 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62299394 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61396942 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61250300 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61176671 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60361370 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55980949 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55706613 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54740675 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54143348 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52742329 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51413711 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51244594 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.51226379 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47215404 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45345884 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44984990 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44968651 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44361792 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.44174893 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.42750268 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41498827 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41485769 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39834521 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39581112 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39320186 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38888191 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.38270118 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36860832 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33739475 |
| 126 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.22508269 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22386558 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.22385888 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.21760979 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.19743719 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16893880 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14037754 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.13921122 |
| 134 | Ribosome_Homo sapiens_hsa03010 | 0.12893352 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.12664620 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.11493900 |
| 137 | Tight junction_Homo sapiens_hsa04530 | 0.10000501 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.05727073 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.05386634 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05232545 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.05205466 |
| 142 | Thyroid cancer_Homo sapiens_hsa05216 | 0.04853075 |
| 143 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.03099667 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0843575 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0673913 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0649719 |
| 147 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0415747 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0288561 |
| 149 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0252104 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0179748 |
| 151 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0056386 |

